Author:
Azimi Pirsaraei Vanoushe,Jozpanahi Manizhe,Kamali Koorosh,Hamzeloo Leila,Saeid Seyedeh Pegah
Publisher
Springer Science and Business Media LLC
Reference28 articles.
1. Thromboembolic risk and anticoagulant therapy in COVID-19 patients: emerging evidence and call for action;Kollias A;Br J Haematol,2020
2. Coronavirus disease 2019 (COVID-19): a clinical update;Zhou M;Front Med,2020
3. Clinical manifestation, diagnosis, prevention and control of SARS-CoV-2 (COVID-19) during the outbreak period;Ozma MA;Infez Med,2020
4. COVID-19 and thrombotic or thromboembolic disease: implications for prevention, antithrombotic therapy, and follow-up: JACC state-of-the-art review;Bikdeli B;J Am Coll Cardiol,2020
5. Venous thromboembolism and heparin use in COVID-19 patients: juggling between pragmatic choices, suggestions of medical societies and the lack of guidelines;Porfidia A;J Thromb Thrombolysis,2020